263 related articles for article (PubMed ID: 25729033)
1. Anti-dsDNA and Antichromatin Antibody Isotypes in Serologically Active Clinically Quiescent Systemic Lupus Erythematosus.
Steiman AJ; Urowitz MB; Ibañez D; Li TT; Gladman DD; Wither J
J Rheumatol; 2015 May; 42(5):810-6. PubMed ID: 25729033
[TBL] [Abstract][Full Text] [Related]
2. Association of antinucleosome antibodies with disease flare in serologically active clinically quiescent patients with systemic lupus erythematosus.
Ng KP; Manson JJ; Rahman A; Isenberg DA
Arthritis Rheum; 2006 Dec; 55(6):900-4. PubMed ID: 17139667
[TBL] [Abstract][Full Text] [Related]
3. Lack of Interferon and Proinflammatory Cyto/chemokines in Serologically Active Clinically Quiescent Systemic Lupus Erythematosus.
Steiman AJ; Gladman DD; Ibañez D; Noamani B; Landolt-Marticorena C; Urowitz MB; Wither JE
J Rheumatol; 2015 Dec; 42(12):2318-26. PubMed ID: 26568589
[TBL] [Abstract][Full Text] [Related]
4. Follow-up and management of serologically active clinically quiescent cases in pediatric systemic lupus erythematosus.
Capone G; Lojacono C; Al-Bayitee F; Makvandi S; Hennon T; Wrotniak B; Abdul-Aziz R
Reumatologia; 2021; 59(4):244-251. PubMed ID: 34538955
[TBL] [Abstract][Full Text] [Related]
5. Anti-dsDNA antibody isotypes in systemic lupus erythematosus: IgA in addition to IgG anti-dsDNA help to identify glomerulonephritis and active disease.
Villalta D; Bizzaro N; Bassi N; Zen M; Gatto M; Ghirardello A; Iaccarino L; Punzi L; Doria A
PLoS One; 2013; 8(8):e71458. PubMed ID: 23951169
[TBL] [Abstract][Full Text] [Related]
6. The antichromatin antibodies can be useful as a diagnostic tool and disease activity marker of systemic lupus erythematosus in Koreans.
Kim HA; Jeon JY; Choi GS; Sung JM; Kim MJ; Yun JM; Suh CH
Clin Immunol; 2008 Aug; 128(2):277-83. PubMed ID: 18504161
[TBL] [Abstract][Full Text] [Related]
7. Outcomes in patients with systemic lupus erythematosus with and without a prolonged serologically active clinically quiescent period.
Steiman AJ; Gladman DD; Ibañez D; Urowitz MB
Arthritis Care Res (Hoboken); 2012 Apr; 64(4):511-8. PubMed ID: 22162433
[TBL] [Abstract][Full Text] [Related]
8. Anti-Double-Stranded DNA Isotypes and Anti-C1q Antibody Improve the Diagnostic Specificity of Systemic Lupus Erythematosus.
Jia Y; Zhao L; Wang C; Shang J; Miao Y; Dong Y; Zhao Z
Dis Markers; 2018; 2018():4528547. PubMed ID: 30363714
[TBL] [Abstract][Full Text] [Related]
9. Selective adsorption of antiphospholipid and anti-dsDNA autoantibodies on histidine based pseudobioaffinity adsorbent from sera of patients with systemic lupus erythematosus (SLE).
Zeinab M; Hiam KM; Edmond C; Assem E
J Chromatogr B Analyt Technol Biomed Life Sci; 2015 Jan; 975():77-83. PubMed ID: 25438246
[TBL] [Abstract][Full Text] [Related]
10. Clinical significance of anti-dsDNA antibody isotypes: IgG/IgM ratio of anti-dsDNA antibodies as a prognostic marker for lupus nephritis.
Förger F; Matthias T; Oppermann M; Becker H; Helmke K
Lupus; 2004; 13(1):36-44. PubMed ID: 14870916
[TBL] [Abstract][Full Text] [Related]
11. BioPlex 2200 multiplexed system: simultaneous detection of anti-dsDNA and anti-chromatin antibodies in patients with systemic lupus erythematosus.
Bardin N; Desplat-Jego S; Daniel L; Jourde Chiche N; Sanmarco M
Autoimmunity; 2009 Jan; 42(1):63-8. PubMed ID: 19127456
[TBL] [Abstract][Full Text] [Related]
12. Anti-chromatin and anti-C1q antibodies in systemic lupus erythematosus compared to other systemic autoimmune diseases.
Braun A; Sis J; Max R; Mueller K; Fiehn C; Zeier M; Andrassy K
Scand J Rheumatol; 2007; 36(4):291-8. PubMed ID: 17763207
[TBL] [Abstract][Full Text] [Related]
13. Constant isotype pattern of anti-dsDNA antibodies in patients with systemic lupus erythematosus.
Winkler TH; Henschel TA; Kalies I; Baenkler HW; Skvaril F; Kalden JR
Clin Exp Immunol; 1988 Jun; 72(3):434-9. PubMed ID: 3262461
[TBL] [Abstract][Full Text] [Related]
14. Treatments and outcomes in Chinese patients with serologically active clinically quiescent systemic lupus erythematosus: a retrospective observational study.
Huang H; Mu L; Zhang Z; Gao D; Hao Y; Zhou W
Arthritis Res Ther; 2021 Oct; 23(1):275. PubMed ID: 34715915
[TBL] [Abstract][Full Text] [Related]
15. Serologically active clinically quiescent systemic lupus erythematosus--predictors of clinical flares.
Walz LeBlanc BA; Gladman DD; Urowitz MB
J Rheumatol; 1994 Dec; 21(12):2239-41. PubMed ID: 7699623
[TBL] [Abstract][Full Text] [Related]
16. The effect of moderate-dose corticosteroids in preventing severe flares in patients with serologically active, but clinically stable, systemic lupus erythematosus: findings of a prospective, randomized, double-blind, placebo-controlled trial.
Tseng CE; Buyon JP; Kim M; Belmont HM; Mackay M; Diamond B; Marder G; Rosenthal P; Haines K; Ilie V; Abramson SB
Arthritis Rheum; 2006 Nov; 54(11):3623-32. PubMed ID: 17075807
[TBL] [Abstract][Full Text] [Related]
17. Antibody clustering helps refine lupus prognosis.
Kessel A; Rosner I; Halasz K; Grushko G; Shoenfeld Y; Paran D; Toubi E
Semin Arthritis Rheum; 2009 Aug; 39(1):66-70. PubMed ID: 18538829
[TBL] [Abstract][Full Text] [Related]
18. Progressive reduction of serum complement levels: a risk factor for relapse in patients with hypocomplementemia in systemic lupus erythematosus.
Miyawaki Y; Sada K; Asano Y; Hayashi K; Yamamura Y; Hiramatsu S; Ohashi K; Morishita M; Watanabe H; Matsumoto Y; Kawabata T; Wada J
Lupus; 2018 Nov; 27(13):2093-2100. PubMed ID: 30309286
[TBL] [Abstract][Full Text] [Related]
19. Performance of anti-C1q, antinucleosome, and anti-dsDNA antibodies for detecting concurrent disease activity of systemic lupus erythematosus.
Mok CC; Ho LY; Leung HW; Wong LG
Transl Res; 2010 Dec; 156(6):320-5. PubMed ID: 21078493
[TBL] [Abstract][Full Text] [Related]
20. Flare, persistently active disease, and serologically active clinically quiescent disease in systemic lupus erythematosus: a 2-year follow-up study.
Conti F; Ceccarelli F; Perricone C; Miranda F; Truglia S; Massaro L; Pacucci VA; Conti V; Bartosiewicz I; Spinelli FR; Alessandri C; Valesini G
PLoS One; 2012; 7(9):e45934. PubMed ID: 23029327
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
